DUSP22 and lung carcinoma: To investigate how DUSP22 suppresses lung cancer development and progression, we stably introduced wild-type DUSP22 expression into various human and mouse lung cancer cell lines (HCC827, H1650, LL/2, H520, and TC-1) because lung cancer cells typically exhibit low endogenous levels of DUSP22 protein expression (Fig. S2A).